By
The Conversation
Published: June 8, 2012, 12:48 p.m.·
Tags:
None
Two large multinational pharmaceutical companies are fighting for patents and monopoly pricing in Indian courts. The outcomes of the cases – involving Novartis and Bayer – are likely to determine the country’s future as a major global supplier of low-cost essential medicines.
Read More →